Skip to main content
. 2017 Jan 24;28(4):855–861. doi: 10.1093/annonc/mdx002

Figure 2.

Figure 2.

Waterfall plot of maximum change in tumor measurements (per RECIST). 58 of 60 patients evaluable for tumor response with both pre- and post-baseline target lesion measurements.